A new Quinnipiac University poll has found that 88% of those in New York support legalizing medical cannabis, with just 9% opposed. The poll marks some of the highest support for medical cannabis in any part of the world.
According to the poll, every age group and political party overwhelmingly supports medical cannabis legalization, including 86% of those 65 and older, and 82% of all Republicans (93% for Democrats, 88% for Independents). 93% of those between the ages of 18 and 29 support the move, the highest of any age group.
The Quinnipiac University poll also found a large majority in the state to be in support of legalizing recreational cannabis; 57% to 39%. Only 13% consider cannabis to be more dangerous than alcohol, and 46% have tried cannabis at least once in their lives .
The full poll results can be found by clicking here.
The post New Poll: 88% in New York Support Legalizing Medical Cannabis appeared first on The Joint Blog.
Although cannabis law reform continues to take place across the country, residents of two states in the U.S. have the opportunity this year to drastically change the landscape in the movement to legalize recreational and medicinal cannabis; Alaska and Florida.
In Alaska, voters will have the opportunity this August to legalize cannabis, through a constitutional amendment, for all adults 21 and older. Similar to Colorado’s Amendment 64, the initiative voters will be considering would legalize cannabis possession, private cultivation and state-licensed sales. If approved, Alaska would become the third state in the U.S. to legalize recreational cannabis; it would be a clear, undeniable sign that cannabis legalization is a certain inevitability, and that recent victories have sped up the process.
In Florida, voters will be given the chance to legalize cannabis for medical purposes this November. Although over 20 states have legalized some form of medical cannabis, Florida would be the first state in the south to do so, and one of the last states many expected would make the move. Despite their often conservative values, recent polling has found upward of 80% in the state to be in support of legalizing medical cannabis, a strong sign that the state will do so through a voter-approved initiative this November.
If both of these states are successful in accomplishing their goal, the momentum gained by the victories in Colorado and Washington would explode to new heights, and new levels of mainsteam awareness.
It’s absolutely vital that those who support reforming our failed cannabis laws support these efforts; if you’re in either of these states, get involved with the campaigns (for Florida click here, for Alaska click here), spread awareness and do what you can to help get these proposals approved. If you’re outside of the state, considering donating to the campaigns behind the initiatives; as we all know, for better or worse, money plays a huge role in politics, and everything you can give helps in a big way.
We’ll keep you updated as these, and other proposals, move forward.
The show that tells truth about marijuana & the politics behind its prohibition. Live call in show http://www.ustream.tv/channel/cannabis-common-sense , Friday's, 8-9PM Pacific Time, 503-288-4442 From: willappel Views: 106 3 ratings Time: 57:32 More in Education
A new study published in this month’s issue of the journal European Neurology, and published online by the U.S. National Institute of Health, has found that Sativex – a medicinal spray made from the cannabis plant – is an effective and safe treatment option for “moderate to severe multiple sclerosis spasticity (MSS)”.
According to researchers: “Nabiximols (Sativex®), a cannabinoid-based oromucosal spray, is an add-on therapy for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The primary objective was to provide real-life observational data of clinical experience of nabiximols in contrast to formal clinical trials of effectiveness.”
Researchers used an “observational, prospective, multicenter, non-interventional” research method with “a follow-up period of 3-4 months”; in total, 335 patients were assessed.
After conducting the study, it was concluded that; “Real-life data confirm nabiximols as an effective and well-tolerated treatment option for resistant MSS in clinical practice.”
The study was conducted by researchers at the Neurological Rehabilitation Center Quellenhof in Germany.
A study published earlier this year by the journal Expert Review of Neurotherapeutics came to a similar conclusion about Sativex, finding it to be an effective treatment for multiple sclerosis spasticity.
The post New Study Finds Cannabinoids An Effective Treatment For Multiple Sclerosis appeared first on The Joint Blog.
Kentucky Agriculture Commissioner James Comer has announced that the state will soon begin hemp pilot projects across the state aimed at researching the various benefits of hemp.
The move is made possible by last year’s passage of Senate Bill 50, which legalized hemp in Kentucky, as well as the recent passage of a national farms bill which included a provision that legalized hemp research in states, like Kentucky, that have legalized hemp.
Comer plans to provide more details on the pilot programs at an event in Eastern Kentucky on Feb. 17th; he says the projects will be located in diverse areas of the state, and will include unique research focuses and different university affiliations.
The post Kentucky Argiculture Commissioner Announces Hemp Cultivation Pilot Programs appeared first on The Joint Blog.